| Year |
Citation |
Score |
| 2015 |
Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY, Noh K, Pecot CV, Rupaimoole R, Stein MA, Brock S, Wen Y, Xiong C, Gharpure K, Hansen JM, ... ... Danes C, et al. Erythropoietin Stimulates Tumor Growth via EphB4. Cancer Cell. PMID 26481148 DOI: 10.1016/J.Ccell.2015.09.008 |
0.65 |
|
| 2009 |
Merritt WM, Danes CG, Shahzad MM, Lin YG, Kamat AA, Han LY, Spannuth WA, Nick AM, Mangala LS, Stone RL, Kim HS, Gershenson DM, Jaffe RB, Coleman RL, Chandra J, et al. Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma. Cancer Biology & Therapy. 8: 1596-603. PMID 19738426 DOI: 10.4161/Cbt.8.16.9004 |
0.399 |
|
| 2009 |
Shahzad MM, Lu C, Lee JW, Stone RL, Mitra R, Mangala LS, Lu Y, Baggerly KA, Danes CG, Nick AM, Halder J, Kim HS, Vivas-Mejia P, Landen CN, Lopez-Berestein G, et al. Dual targeting of EphA2 and FAK in ovarian carcinoma. Cancer Biology & Therapy. 8: 1027-34. PMID 19395869 DOI: 10.4161/Cbt.8.11.8523 |
0.432 |
|
| 2009 |
Neal CL, Yao J, Yang W, Zhou X, Nguyen NT, Lu J, Danes CG, Guo H, Lan KH, Ensor J, Hittelman W, Hung MC, Yu D. 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Research. 69: 3425-32. PMID 19318578 DOI: 10.1158/0008-5472.Can-08-2765 |
0.401 |
|
| 2009 |
Spannuth WA, Nick AM, Jennings NB, Armaiz-Pena GN, Mangala LS, Danes CG, Lin YG, Merritt WM, Thaker PH, Kamat AA, Han LY, Tonra JR, Coleman RL, Ellis LM, Sood AK. Functional significance of VEGFR-2 on ovarian cancer cells. International Journal of Cancer. Journal International Du Cancer. 124: 1045-53. PMID 19058181 DOI: 10.1002/Ijc.24028 |
0.51 |
|
| 2008 |
Danes CG, Wyszomierski SL, Lu J, Neal CL, Yang W, Yu D. 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling. Cancer Research. 68: 1760-7. PMID 18339856 DOI: 10.1158/0008-5472.Can-07-3177 |
0.687 |
|
| Show low-probability matches. |